Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Raw Materials (2020 - 2022)

Rapid Micro Biosystems' Raw Materials history spans 3 years, with the latest figure at $12.6 million for Q2 2022.

  • On a quarterly basis, Raw Materials rose 53.68% to $12.6 million in Q2 2022 year-over-year; TTM through Jun 2022 was $12.6 million, a 53.68% increase, with the full-year FY2021 number at $10.1 million, up 50.06% from a year prior.
  • Raw Materials hit $12.6 million in Q2 2022 for Rapid Micro Biosystems, up from $10.9 million in the prior quarter.
  • Over the last five years, Raw Materials for RPID hit a ceiling of $12.6 million in Q2 2022 and a floor of $6.8 million in Q4 2020.
  • Historically, Raw Materials has averaged $9.8 million across 3 years, with a median of $10.2 million in 2021.
  • Biggest five-year swings in Raw Materials: soared 50.06% in 2021 and later surged 53.68% in 2022.
  • Tracing RPID's Raw Materials over 3 years: stood at $6.8 million in 2020, then soared by 50.06% to $10.1 million in 2021, then increased by 23.92% to $12.6 million in 2022.
  • Business Quant data shows Raw Materials for RPID at $12.6 million in Q2 2022, $10.9 million in Q1 2022, and $10.1 million in Q4 2021.